Answer

Reading File

Running Command

pandoc --track-changes=all "/home/daytona/workspace/attachments/5caf3cce-c3f7-4b23-a405-7fb0fd335b64/major cases 1-1-1.docx" -o /tmp/major_cases.md 2>&1 && cat -n /tmp/major_cases.md | head -200

Running Command

cat -n /tmp/major_cases.md | tail -n +200

Now I have all 10 cases. These are clinical biochemistry major cases - I'll answer all of them comprehensively from my medical knowledge.

MAJOR CASES - Complete Answers

Case 1 - Acute Gouty Arthritis

Scenario: 40-year-old male, excess alcohol, excruciating ankle pain, swollen/red/hot/tender joint, fever, granulocytosis. Serum uric acid = 10 mg/dL.

a) Probable Diagnosis

Acute Gouty Arthritis - classic presentation: monoarthritis (ankle), triggered by alcohol, elevated serum uric acid (normal: 3.5-7.0 mg/dL in males), fever, and granulocytosis indicating acute inflammation.

b) Common Drug and Biochemical Basis of Action

Colchicine is the drug of choice for acute attack.

Biochemical basis: Colchicine binds to tubulin and inhibits its polymerization into microtubules. This prevents neutrophil migration to the joint, inhibits phagocytosis of urate crystals, and blocks the release of inflammatory mediators (lactic acid, lysosomal enzymes). It does NOT lower uric acid but suppresses the inflammatory response.

Allopurinol is used for long-term prophylaxis:

Biochemical basis: It is a structural analogue of hypoxanthine. It competitively inhibits xanthine oxidase, the enzyme that converts hypoxanthine → xanthine → uric acid. This reduces uric acid synthesis.

c) Why Increased Uric Acid?

Alcohol causes hyperuricemia by two mechanisms:

Increased uric acid production: Ethanol metabolism increases NADH, which promotes purine catabolism, generating more hypoxanthine/xanthine → uric acid via xanthine oxidase.
Decreased uric acid excretion: Alcohol raises blood lactate (lactic acidosis). Lactate competes with urate for tubular secretion in the kidney, reducing uric acid excretion → hyperuricemia.

d) Conditions Associated with Hyperuricemia

Category	Examples
Increased production	Gout, Lesch-Nyhan syndrome (HGPRT deficiency), myeloproliferative disorders, psoriasis, high-purine diet
Decreased excretion	Chronic renal failure, drugs (thiazides, low-dose aspirin, cyclosporine), lead nephropathy, hypertension
Combined mechanism	Alcohol consumption, glucose-6-phosphatase deficiency (Von Gierke's disease)
Secondary causes	Hemolytic anemias, tumor lysis syndrome, chemotherapy

Case 2 - Diabetic Ketoacidosis (DKA)

Scenario: Known diabetic, unconscious, Kussmaul breathing, fruity odour (acetone), dehydration, blood sugar 526 mg/dL, pH 7.1, Benedict's and Rothera's positive.

e) Probable Diagnosis

Diabetic Ketoacidosis (DKA) Classic triad: hyperglycemia (526 mg/dL) + acidosis (pH 7.1) + ketonemia/ketonuria (Rothera's positive).

f) Cause for Decrease in Blood pH

In DKA, absolute insulin deficiency leads to:

Increased lipolysis → excess free fatty acids released from adipose tissue
In liver, FFAs undergo beta-oxidation → excess acetyl-CoA
Acetyl-CoA is diverted to ketogenesis → production of ketone bodies: acetoacetate, beta-hydroxybutyrate, and acetone
Acetoacetic acid and beta-hydroxybutyric acid are strong organic acids - they dissociate and release H⁺ ions into blood
The H⁺ load overwhelms the bicarbonate buffer system → metabolic acidosis → pH falls below 7.35 (here 7.1 = severe)

Kussmaul breathing is the compensatory respiratory mechanism to blow off CO₂ and raise pH.

g) Purpose of Doing Rothera's Test

Rothera's test detects ketone bodies (ketonuria) in urine, specifically acetoacetate and acetone.

A positive Rothera's test confirms ketosis, distinguishing DKA from simple hyperglycemic hyperosmolar state (HHS/HONK) where ketones are absent.
It uses sodium nitroprusside (legal purple/lilac colour = positive).

h) Ketone Bodies

Three ketone bodies:

Acetoacetate (acetoacetic acid) - the primary ketone body
Beta-hydroxybutyrate (beta-hydroxybutyric acid) - most abundant in severe DKA (ratio BHB:AcAc = 3:1 in DKA)
Acetone - formed by spontaneous decarboxylation of acetoacetate; responsible for fruity breath

i) How to Detect Acetone by Physical Examination

Acetone is volatile and exhaled through the lungs. On physical examination, the characteristic fruity or "pear-drop" odour of the patient's breath detects acetone. This is called acetone/ketone breath and is a hallmark clinical sign of ketosis/DKA - it can be detected simply by smelling the patient's exhaled breath.

Case 3 - Hemolytic Jaundice (Post-malarial)

Scenario: History of malaria treatment 1 month ago. Total bilirubin 2.5 mg/dL, direct 0.4 mg/dL, indirect 2.1 mg/dL. SGOT/SGPT normal. Urine: urobilinogen positive, bile pigments absent.

a) Probable Diagnosis

Hemolytic (Pre-hepatic) Jaundice - secondary to malaria-induced hemolysis.

Predominantly elevated indirect (unconjugated) bilirubin
Normal liver enzymes (SGOT/SGPT normal)
No bile pigments in urine (unconjugated bilirubin is not water-soluble, cannot be filtered)
Increased urinary urobilinogen

b) Cause for Increased Serum Bilirubin

In malaria, the Plasmodium parasite infects and destroys RBCs (hemolysis). Massive breakdown of RBCs releases large amounts of hemoglobin:

Hb → heme + globin
Heme → biliverdin (via heme oxygenase) → unconjugated bilirubin (in reticuloendothelial cells)
The liver is overwhelmed and cannot conjugate all the bilirubin produced
Result: elevated indirect (unconjugated) bilirubin

c) Test for Estimation of Serum Bilirubin

Van den Bergh's reaction / Diazo reaction (Malloy-Evelyn method)

Bilirubin reacts with diazotized sulfanilic acid (Ehrlich's diazo reagent) to form a purple/violet azo pigment
Direct reaction: Conjugated bilirubin reacts directly (aqueous, water-soluble)
Indirect reaction: Unconjugated bilirubin requires addition of alcohol (methanol) to react
Normal values: Total ≤1.0 mg/dL; Direct ≤0.3 mg/dL; Indirect ≤0.7 mg/dL

d) Reason for Increased Urobilinogen

Excess unconjugated bilirubin reaches the liver → conjugated → excreted in bile into intestine
Gut bacteria reduce conjugated bilirubin → urobilinogen (increased production due to excess bilirubin load)
Some urobilinogen is reabsorbed via enterohepatic circulation → reaches kidney → excreted in urine
Since more bilirubin reaches the gut, more urobilinogen is formed and more is excreted in urine → increased urinary urobilinogen

e) Test to Detect Urinary Urobilinogen

Ehrlich's Aldehyde test (Wallace-Diamond test)

Urobilinogen reacts with p-dimethylaminobenzaldehyde (Ehrlich's reagent) in HCl
Positive result: Cherry-red/pink colour
Confirmatory: The colour does NOT disappear on addition of saturated sodium acetate (distinguishes from porphobilinogen which also gives a similar reaction but does disappear)

Case 4 - Alkaptonuria

Scenario: Child's urine darkens on air exposure, napkin stained dark. Benedict's positive (bright red precipitate), GOD-POD negative, Ferric chloride - transient blue colour.

a) Probable Diagnosis

Alkaptonuria (Ochronosis) - inborn error of aromatic amino acid metabolism.

b) Enzyme Defect

Homogentisate oxidase (homogentisic acid oxidase) deficiency.

This enzyme normally catalyzes the conversion of homogentisic acid → maleylacetoacetic acid in the tyrosine/phenylalanine degradation pathway.
Deficiency leads to accumulation and urinary excretion of homogentisic acid.

c) Why Urine Becomes Dark on Exposure to Air

Homogentisic acid (a reducing substance) is excreted in urine. On exposure to air, homogentisic acid undergoes oxidation and polymerization to form benzoquinone acetic acid and then a dark brown-black melanin-like pigment (alkapton). This reaction is accelerated in alkaline conditions.

d) Why Benedict's Test Positive and GOD-POD Test Negative

Benedict's test positive: Homogentisic acid is a reducing substance (has a free aldehyde/reducing group). It reduces cupric ions (Cu²⁺) in Benedict's reagent to cuprous oxide (Cu₂O), giving a bright red/orange precipitate. Benedict's test is non-specific - it detects ALL reducing substances, not just glucose.
GOD-POD test negative: This test uses glucose oxidase enzyme, which is highly specific for glucose only. Homogentisic acid is NOT glucose, so the glucose oxidase cannot act on it → no reaction → no pink colour.

e) Biochemical Investigation Useful for Diagnosis

Ferric chloride test on urine: gives a transient blue/green colour with homogentisic acid (as in this case).

More definitive investigations:

Paper/thin-layer chromatography of urine - identifies homogentisic acid
HPLC (High-Performance Liquid Chromatography) - quantitative estimation of homogentisic acid in urine
DNA analysis - mutation in HGD gene (chromosome 3q)

Case 5 - Multiple Myeloma

Scenario: 30-year-old, severe back pain, ex-X-ray technician, serum total protein 10 g/dL, albumin 2.8 g/dL, Bence Jones proteins in urine, M-band on electrophoresis, decreased bone density on X-ray.

a) Probable Diagnosis

Multiple Myeloma (Plasma cell myeloma)

Elevated total protein with M-band = monoclonal immunoglobulin (paraprotein)
Bence Jones proteins in urine (pathognomonic)
Lytic bone lesions → back pain, decreased bone density
Low albumin (hypoalbuminemia due to protein loss and chronic disease)

b) Cause for Increase in Serum Total Protein

Malignant proliferation of plasma cells in bone marrow leads to overproduction of a monoclonal immunoglobulin (M-protein/paraprotein), usually IgG or IgA. This monoclonal protein accumulates in blood → elevated total serum protein (hyperproteinemia). The increase is in the globulin fraction (normal albumin/low albumin + elevated globulin = reversed A:G ratio).

c) Can Past History of Working Help Diagnosis?

Yes. Exposure to ionizing radiation (X-rays) over 3+ years is a known risk factor for multiple myeloma. Prolonged occupational radiation exposure can cause DNA damage and chromosomal mutations in B-lymphocytes/plasma cell precursors, potentially triggering malignant transformation. However, radiation is not the sole cause - it is a contributing risk factor.

d) Bence Jones Proteins

Bence Jones proteins are free monoclonal immunoglobulin light chains (either kappa κ or lambda λ) produced in excess by malignant plasma cells
They are too small (MW ~22,000-44,000 Da) to be retained by the glomerular filtration barrier → freely filtered into urine
Classic property: They precipitate at 40-60°C when urine is heated, then redissolve at 100°C, and reprecipitate on cooling - the Bence Jones heat test
Detection confirms plasma cell dyscrasia (myeloma, Waldenström's macroglobulinemia)

e) Conditions Where M-Band Appears on Protein Electrophoresis

Condition	Immunoglobulin Type
Multiple myeloma	IgG (most common), IgA, IgD, IgE, or free light chains
Waldenström's macroglobulinemia	IgM
Monoclonal gammopathy of undetermined significance (MGUS)	Any
Plasmacytoma (solitary)	Any
B-cell lymphoma/CLL	Any
Primary amyloidosis (AL)	Light chains
Heavy chain disease	Heavy chains only

Case 6 - Beta-Thalassemia Major

Scenario: 6-month-old infant, pallor, hepatosplenomegaly, enlarged head. Parents: consanguineous marriage. Hb 3 g%, MCV 45 fL (microcytic), hypochromic, target cells, HbA2 elevated, HbF 20%, HbF+HbA fused bands, HbS solubility negative, stability test positive.

a) Probable Diagnosis

Beta-Thalassemia Major (Cooley's anemia)

b) Biochemical Defect

Absent or markedly reduced synthesis of beta-globin chains due to mutations in the beta-globin gene (chromosome 11):

β0 thalassemia: Complete absence of beta chains
β+ thalassemia: Reduced (but not absent) beta chain synthesis
Result: Excess alpha chains precipitate within RBCs → hemolysis; compensatory increase in HbF (α₂γ₂) and HbA₂ (α₂δ₂)

c) Why HbF and HbA₂ Are Increased

HbF (fetal hemoglobin, α₂γ₂): Normally declines after birth as gamma chains are replaced by beta chains. In beta-thalassemia, beta chain production is absent/reduced → gamma chain synthesis is NOT suppressed → HbF persists and increases as a compensatory mechanism
HbA₂ (α₂δ₂): Delta chains compensate partially for deficient beta chains → HbA₂ increases (normal: <3.5%, elevated to >4% in beta-thal trait; markedly elevated in thalassemia)

d) Why Hb, PCV, MCV Are Decreased (Note: the question asks "increased" but these are actually decreased - this is the typical thalassemia pattern)

Reduced Hb: Decreased beta chains → less functional HbA (α₂β₂) → less hemoglobin per cell
Reduced MCV: Less Hb synthesis → smaller RBCs → microcytosis (MCV 45 fL, normal 80-100 fL)
Reduced PCV: Due to overall anemia and reduced RBC size
The anemia results from: (1) reduced Hb synthesis, (2) ineffective erythropoiesis (intramedullary hemolysis of RBC precursors), and (3) peripheral hemolysis

e) Treatment

Treatment	Details
Regular blood transfusions	Every 2-4 weeks to maintain Hb >9 g/dL; prevents bone marrow expansion (skull enlargement)
Iron chelation therapy	Deferoxamine (desferrioxamine) or deferasirox - to treat transfusion-related iron overload (hemosiderosis)
Folic acid supplementation	Due to increased erythropoietic demands
Hydroxyurea	Increases HbF production (beneficial)
Bone marrow/stem cell transplantation	Only curative treatment
Splenectomy	If hypersplenism develops (reduces transfusion requirements)

Case 7 - Kwashiorkor (Protein-Energy Malnutrition)

Scenario: 2.5-year-old, low socioeconomic status, loss of appetite, diarrhoea, recurrent infections, generalised oedema, distended abdomen. Hb 5 g%, total protein 5.2 g/dL, albumin 2 g/dL. Urine protein absent. Reduced serum copper, magnesium, potassium.

a) Probable Diagnosis

Kwashiorkor - protein-deficient malnutrition (adequate calorie intake but severe protein deficiency)

b) Normal Levels

Parameter	Normal Range
Serum total protein	6.0 - 8.0 g/dL
Serum albumin	3.5 - 5.0 g/dL
Serum globulin	2.0 - 3.5 g/dL
A:G ratio	1.5:1 to 2.5:1 (approximately 1.7:1)

c) Conditions with Decreased Total Serum Protein (Hypoproteinemia)

Decreased synthesis: Liver cirrhosis, hepatitis, malnutrition (kwashiorkor, marasmus), malabsorption
Increased loss: Nephrotic syndrome (proteinuria), protein-losing enteropathy, burns, exudative wounds
Increased catabolism: Fever, sepsis, malignancy, hyperthyroidism
Dilutional: Overhydration, excessive IV fluids, SIADH
Congenital: Analbuminemia (rare)

d) Daily Requirement of Proteins

Adults: 0.8 - 1.0 g/kg body weight/day (RDA: ~50-60 g/day)
Children (1-3 years): ~1.1-1.5 g/kg/day
Infants: ~1.5-2.0 g/kg/day
Pregnancy/lactation: Additional 15-25 g/day above normal requirement
Athletes/critically ill: 1.2-2.0 g/kg/day

e) Cause of Generalized Oedema

Hypoalbuminemia is the key mechanism:

Albumin is the major protein responsible for maintaining plasma oncotic (colloid osmotic) pressure (normal ~25 mmHg)
In kwashiorkor, severe protein deficiency → markedly reduced albumin (2 g/dL here, normal >3.5 g/dL)
Low albumin → reduced plasma oncotic pressure → fluid shifts from intravascular compartment into interstitial spaces (Starling's forces imbalance)
Result: pitting oedema (periorbital, dependent, ascites/distended abdomen)
Note: Urine protein is absent - this is NOT nephrotic syndrome; the oedema is purely due to hypoalbuminemia from dietary deficiency

Case 8 - Glycogen Storage Disease Type 0 / Pompe Disease / GSD Type III

Scenario: 3-month-old girl, liver dysfunction, muscular weakness, hepatomegaly, morning hypoglycemia, hyperlipidemia, ketoacidosis, liver glycogen 6% (elevated, normal <5%), muscle biopsy same, SGOT/SGPT normal, pH 7.25.

a) Diagnosis

Glycogen Storage Disease (GSD) Type III (Cori's Disease / Debrancher enzyme deficiency) - or alternatively GSD Type II (Pompe disease) given muscle + liver involvement.

Most likely: GSD Type III (Cori's Disease) - involves both liver AND muscle, causes fasting hypoglycemia, elevated glycogen in both tissues, with relative preservation of liver enzymes initially.

b) Why Morning Hypoglycemia and Hyperlipidemia?

Fasting hypoglycemia: During overnight fast, blood glucose cannot be maintained because glycogen cannot be fully mobilized (debrancher enzyme is absent → glycogen breakdown is incomplete; only outer glucose residues can be released). This leads to hypoglycemia by morning.
Hyperlipidemia: Hypoglycemia → low insulin, high glucagon → stimulates lipolysis → increased free fatty acids → liver converts FFAs to VLDL/triglycerides → hyperlipidemia. Also, glucose cannot be made from glycogen, so fat becomes the primary fuel.

c) Biochemical Defect

Amylo-1,6-glucosidase (debrancher enzyme) deficiency

Normally, glycogen phosphorylase cleaves alpha-1,4 linkages down to 4 glucose residues from a branch point; then debrancher enzyme (with transferase and glucosidase activities) removes branch points
Without debrancher enzyme → abnormal glycogen with short outer chains (limit dextrin) accumulates in liver and muscle

d) Why Ketoacidosis?

Inability to mobilize glucose from glycogen → fasting hypoglycemia → insulin falls, glucagon rises
Increased lipolysis → excess acetyl-CoA in liver
Acetyl-CoA enters ketogenesis → overproduction of acetoacetate and beta-hydroxybutyrate → ketoacidosis (pH 7.25 confirms metabolic acidosis)

e) Treatment

Frequent high-carbohydrate meals (avoid prolonged fasting)
Cornstarch therapy - uncooked cornstarch acts as a slow-release glucose source; given orally every 4-6 hours to prevent hypoglycemia
High-protein diet - protein (amino acids) can provide gluconeogenic substrates
Avoidance of fasting (especially overnight)
For Pompe disease variant: Enzyme replacement therapy (ERT) with alglucosidase alfa (Myozyme)
Liver transplant in severe hepatic cases

Case 9 - Acute Myocardial Infarction (AMI) in a Diabetic

Scenario: 60-year-old diabetic, acute chest pain, sweating. Glucose 300 mg/dL, cholesterol 350 mg/dL, SGOT 50 IU/L, SGPT 10 IU/L, LDH 10 IU/L (likely a typo - usually elevated in AMI), CK-MB 40 IU/L.

a) Probable Diagnosis

Acute Myocardial Infarction (AMI) in a known diabetic with hypercholesterolemia.

Elevated CK-MB (most specific early marker) + elevated SGOT (AST) with normal SGPT (ALT) = cardiac, not hepatic source
Hyperglycemia in a diabetic under stress

b) Normal Ranges

Parameter	Normal Range
Serum cholesterol	<200 mg/dL (desirable); 200-239 borderline; >240 high
SGOT (AST)	10 - 40 IU/L
SGPT (ALT)	7 - 56 IU/L
LDH (total)	140 - 280 IU/L
CK-MB	<5% of total CK; absolute <25 IU/L

c) Whether Separation of LDH Isoenzymes is Useful in Diagnosis

Yes, it is very useful:

LDH has 5 isoenzymes (LDH₁ through LDH₅)
LDH₁ (H₄) and LDH₂ (H₃M₁): Predominantly in heart, RBCs, kidneys
In AMI: LDH₁ > LDH₂ (LDH flip) - normally LDH₂ > LDH₁
This "flipped ratio" (LDH₁/LDH₂ > 1) is highly specific for myocardial damage
LDH peaks at 48-72 hours and remains elevated for 7-14 days (useful for late diagnosis when troponins may be missed)
LDH₅ is elevated in liver disease/skeletal muscle damage

d) Isoenzymes of CK and When CK-MB is Increased

CK has 3 isoenzymes:

Isoenzyme	Subunits	Location
CK-MM (CK-3)	M+M	Skeletal muscle (predominant), heart
CK-MB (CK-2)	M+B	Myocardium (most specific cardiac marker)
CK-BB (CK-1)	B+B	Brain, smooth muscle, lung

CK-MB increased in:

Acute myocardial infarction (primary and most important)
Myocarditis
Cardiac surgery / cardiac trauma
Severe skeletal muscle injury (minor amounts)
Muscular dystrophies (some cases)
Malignant hyperthermia

e) Why Cholesterol is Increased

In a diabetic:

Insulin deficiency/resistance → impaired activation of lipoprotein lipase (LPL) → reduced VLDL clearance → hypertriglyceridemia + elevated LDL-cholesterol
Increased hepatic VLDL synthesis (due to excess FFA flux from adipose tissue)
Decreased HDL-cholesterol (cardioprotective HDL is lowered in diabetes)
Diabetic dyslipidemia is a major risk factor for atherosclerosis → coronary artery disease → AMI

Case 10 - Nephrotic Syndrome

Scenario: 4-year-old boy, facial and generalized oedema. Total protein 3 g/dL, cholesterol 600 mg/dL, blood urea 80 mg/dL, serum creatinine 4.5 mg/dL, urine protein ++++.

a) Probable Diagnosis

Nephrotic Syndrome (most likely Minimal Change Disease at this age)

Classic pentad: massive proteinuria (≥3.5 g/day) + hypoproteinemia + hypoalbuminemia + oedema + hyperlipidemia

b) Cause for Hypoproteinemia

Massive urinary loss of proteins (urine protein ++++):

The diseased glomerular basement membrane loses its charge and size selectivity
Large amounts of plasma proteins, especially albumin (negatively charged, 68 kDa), are lost in urine
Urinary protein loss exceeds the liver's synthetic capacity → hypoproteinemia/hypoalbuminemia
Serum total protein here: 3 g/dL (normal 6-8 g/dL) - severely reduced

c) Cause for Oedema

Same mechanism as Case 7:

Massive loss of albumin in urine → severe hypoalbuminemia
Reduced plasma oncotic pressure → Starling forces shift fluid into interstitium
Generalized pitting oedema and facial (periorbital) oedema - classic in children with nephrotic syndrome
Sodium and water retention (secondary hyperaldosteronism) worsens the oedema

d) Reason for Hyperlipidemia (Cholesterol 600 mg/dL)

Two mechanisms:

Compensatory hypersynthesis: Low plasma oncotic pressure (from hypoalbuminemia) stimulates the liver to increase synthesis of ALL proteins non-selectively, including lipoproteins (VLDL, LDL) → hyperlipidemia
Reduced catabolism: Lipoprotein lipase (LPL) and hepatic lipase activity is reduced (LPL is lost in urine); LPL activator (apolipoprotein C-II) is also lost in urine → reduced clearance of VLDL and chylomicrons → lipid accumulation

Result: Hypercholesterolemia + hypertriglyceridemia = lipiduria (lipids in urine = oval fat bodies)

e) Why Blood Urea and Serum Creatinine Are Increased

Impaired glomerular filtration rate (GFR):

In nephrotic syndrome, the damaged glomeruli have reduced filtration capacity
Blood urea (80 mg/dL, normal 7-20 mg/dL) and creatinine (4.5 mg/dL, normal 0.6-1.2 mg/dL) are nitrogenous waste products filtered entirely by the glomerulus
Reduced GFR → retention of urea and creatinine → azotemia
This indicates significant renal dysfunction (creatinine 4.5 mg/dL = severe impairment, possibly nephritic-nephrotic overlap or FSGS in this child)
Serum creatinine is a more reliable indicator of GFR than urea (urea is affected by diet, hydration)

Summary Table of Diagnoses:

Case	Diagnosis
1	Acute Gouty Arthritis
2	Diabetic Ketoacidosis (DKA)
3	Hemolytic (Pre-hepatic) Jaundice - post-malaria
4	Alkaptonuria
5	Multiple Myeloma
6	Beta-Thalassemia Major
7	Kwashiorkor
8	Glycogen Storage Disease Type III (Cori's Disease)
9	Acute Myocardial Infarction (in diabetic)
10	Nephrotic Syndrome

I have viva on whole sylabbus of biochem and i have only 3 hours to complete can you please help me go through this

Asking for Preferences

Finding Sources

Reading File

Finding Sources

Here is your complete MBBS 1st Year Biochemistry Viva Flash-Card Set - organized by unit, timed to fit 3 hours (~18 min per unit). Read the Q, cover the A, then check.

🧪 BIOCHEMISTRY VIVA - COMPLETE FLASH CARDS

MBBS 1st Year | All Units

⏱ UNIT 1: CELL BIOLOGY & BIOMOLECULES (~15 min)

Q: What is the fluid mosaic model? A: Singer & Nicolson (1972). Cell membrane = phospholipid bilayer with proteins floating in it like a mosaic. Proteins can be integral (transmembrane) or peripheral. The bilayer is fluid (lateral movement of lipids).

Q: Name the organelles and their functions. A:

Nucleus - DNA storage, transcription
Mitochondria - ATP synthesis (powerhouse), site of TCA cycle, beta-oxidation, ETC
Ribosome - protein synthesis (translation)
Rough ER - synthesis of secretory/membrane proteins
Smooth ER - lipid synthesis, drug detoxification, Ca²⁺ storage
Golgi apparatus - post-translational modification, sorting, secretion
Lysosome - intracellular digestion (acid hydrolases, pH 4.8)
Peroxisome - beta-oxidation of very long chain fatty acids, H₂O₂ metabolism (catalase)
Cytoskeleton - actin (microfilaments), tubulin (microtubules), intermediate filaments

Q: What are the 4 types of biomolecules? A: Carbohydrates, Lipids, Proteins, Nucleic acids

Q: What is a buffer? Give the Henderson-Hasselbalch equation. A: A buffer resists changes in pH. HH equation: pH = pKa + log [A⁻]/[HA]. Most important body buffer: bicarbonate (H₂CO₃/HCO₃⁻), pKa = 6.1.

Q: What is pKa? A: The pH at which 50% of the acid is dissociated (i.e., [HA] = [A⁻]). A good buffer works best within ±1 pH unit of its pKa.

⏱ UNIT 2: CARBOHYDRATES (~20 min)

Q: Define monosaccharide, disaccharide, polysaccharide. A:

Mono: single sugar unit (glucose, fructose, galactose)
Di: two units joined by glycosidic bond (maltose, sucrose, lactose)
Poly: many units (starch, glycogen, cellulose)

Q: What type of bond joins glucose in glycogen vs. cellulose? A: Glycogen: alpha-1,4 glycosidic bonds (main chain) + alpha-1,6 (branch points). Cellulose: beta-1,4 glycosidic bonds (humans cannot digest it - no beta-glucosidase).

Q: What is the Haworth projection? What is mutarotation? A: Haworth projection shows ring structure of sugars. Mutarotation = interconversion between alpha and beta anomers of a sugar in solution until equilibrium is reached. Glucose: alpha-D-glucose (36%) ⇌ beta-D-glucose (64%) at equilibrium.

Q: What are reducing sugars? How are they detected? A: Sugars with a free aldehyde or ketone group that can reduce Cu²⁺ in Benedict's reagent → Cu₂O (orange/red precipitate). All monosaccharides + maltose, lactose are reducing. Sucrose is NON-reducing.

Q: What is the pathway of glycolysis? Where does it occur? A: Cytoplasm. Glucose (6C) → Pyruvate (3C). Net yield: 2 ATP + 2 NADH + 2 pyruvate per glucose. Key enzymes: Hexokinase/Glucokinase → PGI → PFK-1 (rate-limiting) → Aldolase → TPI → GAPDH → PGK → PGM → Enolase → Pyruvate kinase

Q: What is the rate-limiting enzyme of glycolysis? A: Phosphofructokinase-1 (PFK-1). Activated by AMP, ADP, fructose-2,6-bisphosphate. Inhibited by ATP, citrate.

Q: What is the Pasteur effect? A: In the presence of oxygen, aerobic respiration inhibits glycolysis (fermentation is suppressed). Oxygen suppresses lactic acid production.

Q: What happens to pyruvate under aerobic vs. anaerobic conditions? A: Aerobic: Pyruvate → Acetyl-CoA (by pyruvate dehydrogenase complex, in mitochondria). Anaerobic: Pyruvate → Lactate (by LDH, in cytoplasm) - regenerates NAD⁺.

Q: What is the pyruvate dehydrogenase complex? What cofactors does it need? A: Multi-enzyme complex (E1-pyruvate decarboxylase, E2-dihydrolipoamide acetyltransferase, E3-dihydrolipoamide dehydrogenase). Cofactors: TPP (Vit B1), Lipoamide (Lipoic acid), FAD (Vit B2), NAD⁺ (Vit B3), CoA (Vit B5) - mnemonic: "The Lovely Five Nutrients Create Acetyl-CoA"

Q: Name the steps and products of TCA cycle. A: In mitochondrial matrix. Acetyl-CoA (2C) + OAA (4C) → Citrate (6C) → Isocitrate → alpha-ketoglutarate (CO₂ released) → Succinyl-CoA (CO₂ released) → Succinate → Fumarate → Malate → OAA. Per turn: 3 NADH + 1 FADH₂ + 1 GTP + 2 CO₂

Q: What is the total ATP yield from one glucose (aerobic)? A: 30-32 ATP (modern estimate). Older textbooks: 36-38 ATP.

Glycolysis: 2 ATP + 2 NADH (cytoplasmic)
Pyruvate dehydrogenase: 2 NADH
TCA (×2): 6 NADH + 2 FADH₂ + 2 GTP
ETC: each NADH ≈ 2.5 ATP; each FADH₂ ≈ 1.5 ATP

Q: What is gluconeogenesis? Where does it occur? A: Synthesis of glucose from non-carbohydrate precursors. Occurs mainly in liver (90%), some in kidney. Precursors: lactate, pyruvate, glycerol, glucogenic amino acids (all except leucine & lysine).

Q: What are the 4 unique enzymes of gluconeogenesis (bypassing irreversible glycolysis steps)? A:

Pyruvate carboxylase (pyruvate → OAA; requires biotin)
PEPCK (OAA → PEP)
Fructose-1,6-bisphosphatase (F-1,6-BP → F-6-P)
Glucose-6-phosphatase (G-6-P → glucose; only in liver/kidney)

Q: What is the Cori cycle? A: Lactate produced by muscle/RBCs (anaerobic glycolysis) is transported to liver → converted back to glucose by gluconeogenesis → released into blood → used again by muscle. Transfers metabolic burden from muscle to liver.

Q: What is glycogen synthesis? Which enzyme is rate-limiting? A: Glucose → G-6-P → G-1-P → UDP-glucose → glycogen. Glycogen synthase is rate-limiting. Branching enzyme adds alpha-1,6 branches.

Q: What is glycogen breakdown? A: Glycogen phosphorylase (rate-limiting) cleaves alpha-1,4 bonds → G-1-P → G-6-P → glucose (in liver). Debranching enzyme cleaves alpha-1,6 bonds at branch points.

Q: What is the HMP shunt (Pentose Phosphate Pathway)? Significance? A: Alternate pathway for glucose oxidation in cytoplasm. Produces:

NADPH - for biosynthesis (fatty acids, cholesterol) and antioxidant defence (regenerates GSH)
Ribose-5-phosphate - for nucleotide/nucleic acid synthesis Rate-limiting enzyme: Glucose-6-phosphate dehydrogenase (G6PD). Deficiency → hemolytic anemia with oxidant drugs (primaquine, dapsone).

Q: What is the Embden-Meyerhof pathway? A: Another name for glycolysis (classical pathway).

⏱ UNIT 3: LIPIDS (~20 min)

Q: Classify lipids. A:

Simple lipids: triglycerides (fats/oils), waxes
Compound lipids: phospholipids, glycolipids, lipoproteins
Derived lipids: fatty acids, steroids, cholesterol

Q: What is a saturated vs. unsaturated fatty acid? A: Saturated: no double bonds (solid at room temp, e.g., palmitic C16:0, stearic C18:0). Unsaturated: one or more double bonds (liquid at room temp). Monounsaturated: 1 double bond (oleic C18:1). Polyunsaturated: >1 (linoleic C18:2, arachidonic C20:4).

Q: What are essential fatty acids? A: Fatty acids that cannot be synthesized in body; must be obtained from diet.

Linoleic acid (omega-6, C18:2) - precursor of arachidonic acid → prostaglandins
Alpha-linolenic acid (omega-3, C18:3) - precursor of EPA, DHA Deficiency: dermatitis, poor wound healing, growth failure.

Q: What is beta-oxidation? Where does it occur? A: Oxidative degradation of fatty acids in mitochondrial matrix. Fatty acid → Acyl-CoA (cytoplasm, by acyl-CoA synthetase) → transported into mitochondria by carnitine shuttle (carnitine acyltransferase I - rate-limiting) → beta-oxidation loop: FAD → FADH₂, NAD⁺ → NADH, acetyl-CoA released each cycle.

Palmitic acid (C16): 7 cycles → 8 acetyl-CoA + 7 FADH₂ + 7 NADH → 106 ATP net

Q: What is fatty acid synthesis? Where? Rate-limiting enzyme? A: Occurs in cytoplasm (liver, adipose, mammary gland). Acetyl-CoA → Malonyl-CoA → palmitate (C16). Rate-limiting: Acetyl-CoA carboxylase (requires biotin; activated by citrate, inhibited by palmitoyl-CoA).

Fatty acid synthase (FAS) is the multi-enzyme complex.
NADPH is required (from HMP shunt and malic enzyme).

Q: What are ketone bodies? How are they formed? A: Formed in liver mitochondria from excess acetyl-CoA (starvation, DKA):

Acetoacetate (primary)
Beta-hydroxybutyrate (most abundant)
Acetone (volatile, exhaled) Pathway: Acetyl-CoA → Acetoacetyl-CoA → HMG-CoA → Acetoacetate → BHB or Acetone. Rate-limiting enzyme: HMG-CoA synthase.

Q: How are ketone bodies utilized? A: In extrahepatic tissues (brain, heart, muscle - NOT liver, as liver lacks succinyl-CoA transferase/thiophorase): BHB → Acetoacetate → Acetoacetyl-CoA → 2 Acetyl-CoA → TCA → ATP

Q: What is cholesterol synthesis? Rate-limiting enzyme? A: In liver cytoplasm. Acetyl-CoA → HMG-CoA → Mevalonate → → Cholesterol. Rate-limiting: HMG-CoA reductase. Inhibited by statins (lovastatin, atorvastatin) - major drug target for hyperlipidemia.

Q: What are lipoproteins? Classify them. A: Lipid-protein complexes transporting lipids in blood. Classified by density:

Lipoprotein	Major lipid	Apoprotein	Function
Chylomicron	Triglycerides	ApoB-48	Dietary fat from gut to tissues
VLDL	Triglycerides	ApoB-100	Endogenous TG from liver to tissues
IDL	TG + Cholesterol	ApoB-100	Intermediate
LDL	Cholesterol	ApoB-100	"Bad" - delivers cholesterol to cells
HDL	Cholesterol esters	ApoA-I	"Good" - reverse cholesterol transport

Q: What is reverse cholesterol transport? A: HDL collects excess cholesterol from peripheral tissues and transports it back to liver for excretion in bile. Protective against atherosclerosis. Key enzyme: LCAT (Lecithin-Cholesterol AcylTransferase).

Q: What are eicosanoids? A: Bioactive lipids derived from C20 polyunsaturated fatty acids (mainly arachidonic acid).

Prostaglandins (PG): inflammation, pain, fever, uterine contraction
Thromboxanes (TX): platelet aggregation (TXA₂), vasoconstriction
Leukotrienes (LT): bronchoconstriction (asthma), allergic reactions
NSAIDs inhibit COX → block prostaglandin/thromboxane synthesis.

⏱ UNIT 4: PROTEINS & AMINO ACIDS (~20 min)

Q: What are the essential amino acids? A: PVT TIM HaLL - Phenylalanine, Valine, Threonine, Tryptophan, Isoleucine, Methionine, Histidine (semi-essential), Leucine, Lysine. (10 in children including Arginine and Histidine; 8 in adults)

Q: What is a peptide bond? What are its properties? A: Covalent bond between -COOH of one amino acid and -NH₂ of the next, with loss of water. Properties: partial double bond character (resonance) → rigid/planar, NO free rotation. Trans configuration is preferred.

Q: What are the 4 levels of protein structure? A:

Primary: amino acid sequence (peptide bonds)
Secondary: local regular structure: alpha-helix (H-bonds intrachain, 3.6 aa/turn) or beta-pleated sheet (H-bonds interchain)
Tertiary: 3D folding of polypeptide (H-bonds, ionic, hydrophobic, disulfide bonds)
Quaternary: association of 2+ polypeptide subunits (e.g., hemoglobin = α₂β₂)

Q: What is denaturation? A: Loss of secondary/tertiary/quaternary structure without breaking peptide bonds (primary structure intact). Causes: heat, pH extremes, urea, detergents, heavy metals. Usually irreversible.

Q: What are conjugated proteins? Give examples. A: Proteins with a non-protein (prosthetic) group:

Glycoproteins (carbohydrate) - immunoglobulins
Lipoproteins (lipid)
Nucleoproteins (nucleic acid) - histones + DNA
Hemoproteins (heme) - hemoglobin, myoglobin, cytochromes
Metalloproteins (metal) - ceruloplasmin (Cu), ferritin (Fe)
Phosphoproteins (phosphate) - casein (milk)

Q: What is the isoelectric point (pI)? A: The pH at which a protein/amino acid has no net charge (exists as zwitterion). At pI, protein has minimum solubility and does not migrate in electric field. Used in protein electrophoresis.

Q: What is the Biuret test? A: Detects proteins with 2+ peptide bonds. Protein + NaOH + CuSO₄ → violet/purple colour (Cu²⁺ complexes with peptide bonds). Used for estimation of total serum protein.

Q: What is Ninhydrin reaction? A: Detects alpha-amino acids and amino groups. Amino acid + Ninhydrin → blue-purple colour (Ruhemann's purple). Proline and hydroxyproline give a yellow colour. Used in paper chromatography to detect amino acids.

Q: What is transamination? Which enzyme? Which coenzyme? A: Transfer of amino group from one amino acid to a keto acid. Most important: Aspartate aminotransferase (AST/SGOT) and Alanine aminotransferase (ALT/SGPT). Coenzyme: Pyridoxal phosphate (PLP, Vit B6).

Q: What is the significance of SGOT and SGPT? A: Both are released into blood when liver cells are damaged. SGPT (ALT) is more specific for liver (mainly hepatic). SGOT (AST) is found in heart, liver, muscle (less specific). SGOT/SGPT ratio (De Ritis ratio): >2 suggests alcoholic hepatitis or cardiac damage; <1 suggests viral hepatitis.

Q: What is urea cycle? Where? What is its significance? A: Liver (partially in mitochondria, partly in cytoplasm). Converts toxic ammonia → urea (non-toxic) for urinary excretion. Steps: NH₃ + CO₂ → Carbamoyl phosphate → Citrulline → Argininosuccinate → Arginine → Urea + Ornithine.

Rate-limiting: Carbamoyl phosphate synthetase I (mitochondria; requires N-acetylglutamate as activator)
Urea = 2 nitrogen atoms (1 from NH₃, 1 from aspartate)

Q: What is phenylketonuria (PKU)? A: Deficiency of phenylalanine hydroxylase → phenylalanine cannot be converted to tyrosine → accumulates → phenylpyruvate, phenylacetate, phenyllactate excreted in urine (musty/mousy odour). Causes intellectual disability, fair skin (low melanin), eczema. Screening: Guthrie test. Treatment: phenylalanine-restricted diet.

Q: What is alkaptonuria? A: Deficiency of homogentisate oxidase → homogentisic acid accumulates → dark urine on standing, ochronosis (black pigment in connective tissue), arthritis.

Q: What is maple syrup urine disease? A: Deficiency of branched-chain alpha-keto acid dehydrogenase → accumulation of leucine, isoleucine, valine and their keto acids → sweet/maple syrup urine odour, neurological damage.

⏱ UNIT 5: ENZYMES (~20 min)

Q: Define enzyme. What are apoenzyme, holoenzyme, coenzyme, prosthetic group? A:

Enzyme: biological catalyst (mostly protein), speeds up reactions without being consumed
Apoenzyme: inactive protein part alone
Coenzyme: non-protein organic cofactor (loosely bound, e.g., NAD⁺, FAD, CoA)
Prosthetic group: tightly/covalently bound non-protein group (e.g., heme in hemoglobin, FAD in succinate dehydrogenase)
Holoenzyme: apoenzyme + coenzyme/prosthetic group = fully active enzyme

Q: What is the active site? A: Specific region on enzyme where substrate binds and reaction occurs. Two models:

Lock and key model (Fischer): rigid complementarity between enzyme and substrate
Induced fit model (Koshland): enzyme changes shape upon substrate binding (more accurate)

Q: What is Km? Vmax? What do they mean? A:

Km (Michaelis constant): substrate concentration at which reaction velocity = ½ Vmax. Reflects affinity - low Km = high affinity.
Vmax: maximum velocity at saturating substrate concentration; proportional to enzyme concentration.
Michaelis-Menten equation: v = Vmax[S] / (Km + [S])

Q: What is a Lineweaver-Burk plot? A: Double reciprocal plot (1/v vs 1/[S]). Straight line. Y-intercept = 1/Vmax. X-intercept = -1/Km. Slope = Km/Vmax. Used to determine type of inhibition.

Q: What are the types of enzyme inhibition? A:

Type	Km	Vmax	Antidote concept
Competitive	Increases	Unchanged	Overcome by excess substrate; statins, methotrexate, allopurinol
Non-competitive	Unchanged	Decreases	Cannot be overcome by substrate
Uncompetitive	Decreases	Decreases	Both decrease proportionally
Irreversible	-	Decreases permanently	Organophosphates (AChE), penicillin (transpeptidase)

Q: What is allosteric regulation? A: Binding of a regulatory molecule to a site OTHER than the active site (allosteric site) changes enzyme shape and activity. Allosteric activators increase activity; inhibitors decrease it. Follows sigmoidal kinetics (not Michaelis-Menten). Example: PFK-1 (allosteric enzyme in glycolysis).

Q: What are isoenzymes (isozymes)? Give clinical example. A: Multiple forms of the same enzyme, catalyzing the same reaction, but differing in structure, physical/chemical properties. Example: LDH (5 isoenzymes): LDH₁ (heart/RBC), LDH₅ (liver/muscle). CK (3 isoenzymes): CK-MM (muscle), CK-MB (heart), CK-BB (brain).

Q: How are enzymes classified (IUB classification)? A:

Oxidoreductases - oxidation-reduction (LDH, NADH dehydrogenase)
Transferases - group transfer (kinases, aminotransferases)
Hydrolases - hydrolysis (proteases, lipases, amylase)
Lyases - addition/removal across double bonds (aldolase, decarboxylases)
Isomerases - isomerization (PGI, triosephosphate isomerase)
Ligases (Synthetases) - join two molecules using ATP (acetyl-CoA carboxylase, pyruvate carboxylase)

Q: What is the coenzyme role of vitamins? A:

Vitamin	Coenzyme	Pathway
B1 (Thiamine)	TPP	Pyruvate DH, alpha-KG DH, Transketolase
B2 (Riboflavin)	FAD/FMN	ETC, beta-oxidation, TCA
B3 (Niacin)	NAD⁺/NADP⁺	Glycolysis, TCA, HMP shunt
B5 (Pantothenic acid)	CoA	Acetyl-CoA formation, TCA
B6 (Pyridoxine)	PLP	Transamination, decarboxylation
B7 (Biotin)	Carboxylation reactions	Pyruvate carboxylase, Acetyl-CoA carboxylase
B9 (Folate)	THF	1-carbon transfers, DNA synthesis
B12 (Cobalamin)	Methylcobalamin, AdoB12	Methionine synthesis, methylmalonyl-CoA → succinyl-CoA

⏱ UNIT 6: HEMOGLOBIN & PORPHYRIN (~15 min)

Q: What is the structure of hemoglobin? A: Hb = 4 subunits: α₂β₂ (HbA, normal adult, 97%). Each subunit has a globin chain + 1 heme group. Heme = protoporphyrin IX + Fe²⁺ (ferrous). HbA₂ = α₂δ₂ (2.5%). HbF = α₂γ₂ (fetal, high O₂ affinity).

Q: What is the oxygen dissociation curve? What shifts it? A: Sigmoid (S-shaped) curve due to cooperative binding (allosteric). T-state (tense, low O₂ affinity) ⇌ R-state (relaxed, high O₂ affinity). Right shift (decreased O₂ affinity - Bohr effect): increased CO₂, decreased pH, increased temp, increased 2,3-BPG → facilitates O₂ unloading to tissues. Left shift (increased O₂ affinity): HbF, CO poisoning, decreased 2,3-BPG, decreased CO₂, alkalosis.

Q: What is 2,3-BPG? Where is it formed? A: 2,3-bisphosphoglycerate (2,3-BPG). Formed in RBCs by Luebering-Rapoport pathway (from 1,3-BPG). Binds to deoxy-Hb (beta chains), stabilizes T-state → decreases O₂ affinity → shifts curve RIGHT → facilitates O₂ unloading. Increased at high altitude, anemia, chronic hypoxia.

Q: What is the Bohr effect? A: In tissues, CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻. H⁺ binds Hb → destabilizes R-state → O₂ unloads. In lungs, reverse occurs → CO₂ is exhaled → O₂ loads.

Q: What are the types of hemoglobin? A:

HbA (α₂β₂) - 97% of adult Hb
HbA₂ (α₂δ₂) - 2.5%
HbF (α₂γ₂) - fetal; high affinity for O₂ (less 2,3-BPG binding)
HbS (α₂β₂ᔆ) - sickle cell (Glu→Val at position 6 of beta chain)
Methemoglobin - Fe³⁺ (ferric), cannot carry O₂; treated with methylene blue
Carboxyhemoglobin - HbCO (CO poisoning); 200x affinity for CO vs O₂

Q: What is heme synthesis? Rate-limiting step? A: In mitochondria and cytoplasm (erythroid cells and liver). Succinyl-CoA + Glycine → ALA (by ALA synthase, rate-limiting, requires PLP/B6) → Porphobilinogen → Uroporphyrinogen → Coproporphyrinogen → Protoporphyrin IX + Fe²⁺ → Heme

Q: What are porphyrias? A: Inherited defects in heme synthesis enzymes → accumulation of porphyrin precursors. Examples: Acute intermittent porphyria (AIP) - ALA dehydratase or PBG deaminase deficiency → abdominal pain, neuropsychiatric symptoms, port-wine urine. Porphyria cutanea tarda - photosensitivity.

Q: What is heme catabolism? What is bilirubin? A: RBC breakdown → Hb → Heme → Biliverdin (green) → Unconjugated bilirubin (fat-soluble, bound to albumin in blood) → Liver: glucuronyl transferase → Conjugated bilirubin (water-soluble) → Bile → Intestine → Urobilinogen → Urobilin (yellow, in urine) or Stercobilin (brown, in feces).

Q: Distinguish the 3 types of jaundice. A:

Feature	Pre-hepatic (Hemolytic)	Hepatic	Post-hepatic (Obstructive)
Serum bilirubin	Indirect ↑	Both ↑	Direct ↑
Urine bilirubin	Absent	Present	Present (dark urine)
Urine urobilinogen	Increased	Variable	Absent
Stool colour	Normal/dark	Pale	Clay/pale
Cause	Malaria, hemolysis	Hepatitis, cirrhosis	Gallstones, pancreatic CA

⏱ UNIT 7: NUCLEOTIDES & NUCLEIC ACIDS (~15 min)

Q: What is the structure of DNA? A: Double helix (Watson & Crick, 1953). Two antiparallel polynucleotide chains. Purines (A, G) pair with Pyrimidines (T, C) via H-bonds: A=T (2 H-bonds), G≡C (3 H-bonds). Backbone: sugar-phosphate. Right-handed B-DNA is physiological form.

Q: What are purines vs. pyrimidines? A:

Purines (double ring): Adenine (A), Guanine (G) - "PURe As Gold"
Pyrimidines (single ring): Cytosine (C), Thymine (T), Uracil (U) - "CUT the PY"
DNA: A, T, G, C. RNA: A, U, G, C (uracil replaces thymine)

Q: What is nucleoside vs. nucleotide? A: Nucleoside = base + sugar (ribose or deoxyribose). Nucleotide = base + sugar + phosphate group. ATP = adenine + ribose + 3 phosphates.

Q: What is DNA replication? Key enzymes? A: Semi-conservative (Watson, Crick, Meselson-Stahl). Each strand serves as template.

Helicase - unwinds double helix
Topoisomerase - relieves supercoiling/tension
Primase - synthesizes RNA primer
DNA Polymerase III (prokaryotes) / DNA Pol α, δ, ε (eukaryotes) - synthesizes new strand (5'→3' only)
DNA Pol I - removes RNA primer, fills gap
DNA Ligase - seals nicks (joins Okazaki fragments on lagging strand)

Q: What is transcription? A: DNA → mRNA (in nucleus). RNA Polymerase (no primer needed). Template strand read 3'→5', mRNA synthesized 5'→3'. mRNA undergoes processing: 5' cap (7-methyl guanosine), 3' poly-A tail, splicing (introns removed, exons joined).

Q: What is translation? A: mRNA → Protein (on ribosomes). Codons (3 nucleotide each) read by tRNA anticodons. Start codon: AUG (methionine). Stop codons: UAA, UAG, UGA ("Amber, Ochre, Opal" - no amino acid). Ribosomes: 80S eukaryote (60S + 40S), 70S prokaryote (50S + 30S).

Q: What is the genetic code? Properties? A:

64 codons for 20 amino acids
Degenerate/redundant - multiple codons for one amino acid
Unambiguous - one codon codes for only one amino acid
Non-overlapping - each nucleotide read only once
Commaless - no punctuation between codons
Universal - same code in nearly all organisms

Q: What are the types of RNA? A:

mRNA (messenger) - carries genetic info from DNA to ribosome; most unstable
tRNA (transfer) - adaptor; carries amino acids; cloverleaf structure; anticodon loop; most modified bases
rRNA (ribosomal) - structural + catalytic component of ribosomes (peptidyl transferase = ribozyme)
hnRNA (heterogeneous nuclear RNA) - pre-mRNA
snRNA (small nuclear) - splicing (in spliceosomes)

Q: What is de novo vs. salvage pathway of nucleotide synthesis? A:

De novo: synthesis from scratch (amino acids, CO₂, ribose). Expensive in energy. Purines built on ribose directly; pyrimidines ring formed first then attached.
Salvage: recycling of free bases from DNA/RNA degradation. More economical. HGPRT (hypoxanthine-guanine phosphoribosyl transferase) is key enzyme - deficient in Lesch-Nyhan syndrome.

Q: What is Lesch-Nyhan syndrome? A: X-linked recessive. Deficiency of HGPRT → hypoxanthine and guanine cannot be salvaged → excess → uric acid. Features: hyperuricemia, gout, intellectual disability, self-mutilation (biting fingers/lips), choreoathetosis.

⏱ UNIT 8: VITAMINS & MINERALS (~20 min)

Q: Classify vitamins. A:

Fat-soluble: A, D, E, K (stored in liver/fat; toxicity possible with excess)
Water-soluble: B complex (B1,B2,B3,B5,B6,B7,B9,B12) + Vitamin C (not stored; excess excreted)

Q: Vitamin A (Retinol) - sources, deficiency, toxicity? A:

Sources: liver, fish oil, eggs, dairy (preformed); beta-carotene from carrots, green veg (provitamin A)
Function: vision (rhodopsin in rod cells), epithelial integrity, immune function, gene regulation (RAR/RXR)
Deficiency: Night blindness (first sign), Xerophthalmia (dry eye), Bitot's spots, corneal ulceration/keratomalacia, follicular hyperkeratosis
Toxicity: pseudotumor cerebri (raised ICP), hepatomegaly, alopecia, teratogenicity

Q: What is rhodopsin? Explain the visual cycle. A: Rhodopsin = Opsin (protein) + 11-cis-retinal (from Vit A). Light → 11-cis-retinal → all-trans-retinal → nerve impulse (hyperpolarization of rod cell) → brain interprets as vision. In dark, all-trans-retinal recycled back to 11-cis-retinal (requires Vit A).

Q: Vitamin D - synthesis, function, deficiency? A:

Synthesis: Skin (UV light): 7-dehydrocholesterol → Cholecalciferol (D3) → Liver: 25-hydroxylation → 25-OH-D3 → Kidney: 1-alpha-hydroxylation (rate-limiting, stimulated by PTH, hypophosphatemia) → 1,25-(OH)₂-D3 = Calcitriol (active form)
Function: increases intestinal Ca²⁺ and phosphate absorption; promotes bone mineralization; regulates PTH
Deficiency: Children → Rickets (bowing of legs, Harrison's sulcus, craniotabes); Adults → Osteomalacia (bone pain, muscle weakness); Hypocalcemia → tetany

Q: Vitamin E (Tocopherol)? A: Antioxidant - protects polyunsaturated fatty acids (PUFAs) in cell membranes from lipid peroxidation. Scavenges free radicals. Deficiency: hemolytic anemia (in premature infants), spinocerebellar degeneration, peripheral neuropathy.

Q: Vitamin K? A: Required for gamma-carboxylation of glutamate residues in clotting factors II, VII, IX, X (and proteins C, S). Deficiency: bleeding tendency, prolonged PT. Warfarin is a Vitamin K antagonist (anticoagulant). Newborns → given Vit K injection to prevent hemorrhagic disease of newborn.

Q: Vitamin C (Ascorbic acid)? A:

Function: Hydroxylation of proline and lysine in collagen synthesis (by prolyl and lysyl hydroxylase, requires Vit C as cofactor). Also antioxidant, enhances iron absorption, immune function.
Deficiency (Scurvy): Perifollicular hemorrhage, bleeding gums (gingivitis), corkscrew hair, poor wound healing, Woody leg (in children), Scorbutic rosary. Gums bleed because collagen in blood vessel walls is defective.

Q: Vitamin B1 (Thiamine) - deficiency? A: Coenzyme TPP (thiamine pyrophosphate). Required for: pyruvate DH, alpha-KG DH, transketolase (HMP). Deficiency: Beriberi (Wet = cardiac - high output failure; Dry = peripheral neuropathy, polyneuritis) and Wernicke-Korsakoff syndrome (in alcoholics): nystagmus, ataxia, confusion, Korsakoff psychosis/amnesia.

Q: Vitamin B3 (Niacin) - deficiency? What is Hartnup disease? A: Deficiency: Pellagra - "3 Ds": Dermatitis (photosensitive), Diarrhoea, Dementia (+ 4th D = Death if untreated). Casal's necklace = skin lesion around neck. Hartnup disease: defect in intestinal/renal tryptophan absorption → pellagra-like symptoms (tryptophan is precursor for niacin: 60mg Trp → 1mg Niacin).

Q: Vitamin B12 (Cobalamin) - deficiency? A: Requires Intrinsic Factor (IF) secreted by gastric parietal cells for absorption in terminal ileum. Deficiency (pernicious anemia - anti-IF antibodies, or vegans): Megaloblastic anemia (macro-ovalocytes, hypersegmented neutrophils), subacute combined degeneration of spinal cord (posterior + lateral columns → ataxia, paresthesia), glossitis.

Q: Folate - deficiency? A: Megaloblastic anemia (same blood picture as B12, but NO neurological features). Causes: dietary deficiency (most common in developing countries), pregnancy (increased demand), drugs (methotrexate, phenytoin). Supplementation in pregnancy prevents neural tube defects (spina bifida, anencephaly).

Q: What is iron metabolism? A:

Absorption: Non-heme (Fe³⁺ → Fe²⁺ by Vit C, ferric reductase) and heme iron in duodenum/jejunum. Transported by DMT-1 into enterocyte → transferrin in blood → tissues.
Storage: Ferritin (soluble, physiological store; serum ferritin reflects body stores) and Hemosiderin (insoluble, pathological).
Transport protein: Transferrin (Fe³⁺, 2 sites; TIBC = total iron binding capacity).
Regulation: Hepcidin (liver peptide) - master regulator; increased in infection/inflammation → traps iron in macrophages → anemia of chronic disease.
Deficiency: Iron-deficiency anemia - microcytic hypochromic, low serum iron, low ferritin, high TIBC.

Q: What is copper metabolism? A: Absorbed in duodenum. Transported by albumin, then ceruloplasmin (main transport protein; ferroxidase activity). Wilson's disease: AR, ATP7B mutation → copper accumulation in liver, brain, kidney, eye → cirrhosis, neuropsychiatric, Kayser-Fleischer rings (green-brown corneal rings). Treatment: D-penicillamine. Menkes disease (kinky hair): X-linked, ATP7A mutation, defective copper absorption.

Q: What is calcium and phosphate metabolism? A: Serum Ca²⁺ (total): 8.5-10.5 mg/dL; Serum phosphate: 2.5-4.5 mg/dL. Regulated by:

PTH: increases Ca²⁺ (bone resorption, renal reabsorption, activates Vit D), decreases phosphate (renal excretion)
Calcitriol (Vit D): increases Ca²⁺ and phosphate absorption from gut
Calcitonin (thyroid C cells): decreases Ca²⁺ (opposes PTH)

⏱ UNIT 9: HORMONES & SIGNAL TRANSDUCTION (~10 min)

Q: Classify hormones by chemical nature. A:

Peptide/Protein: Insulin, Glucagon, GH, TSH, FSH, LH, PTH, ADH (hydrophilic, receptor on cell surface)
Steroids: Cortisol, Aldosterone, Estrogen, Progesterone, Testosterone, Vit D (from cholesterol; hydrophobic, receptor intracellular)
Amines: Epinephrine/Norepinephrine (from tyrosine; hydrophilic), T3/T4 thyroid hormones (from tyrosine; hydrophobic, nuclear receptor)

Q: What is the mechanism of action of peptide hormones? A: Bind to surface receptors → activate second messengers:

cAMP pathway: Glucagon, Epinephrine (β), TSH, PTH → Gs → Adenylyl cyclase → cAMP → PKA → phosphorylates enzymes (activates glycogenolysis, lipolysis)
IP3/DAG pathway: Epinephrine (α₁), Angiotensin II, Oxytocin → Gq → PLC → IP3 (Ca²⁺ release) + DAG (activates PKC)
Tyrosine kinase pathway: Insulin, IGF, EGF, PDGF → autophosphorylation → downstream signaling (MAPK, PI3K/Akt)

Q: What is insulin? What does it do biochemically? A: Peptide hormone from beta cells of islets of Langerhans. Secreted in response to high blood glucose. Anabolic hormone:

Promotes glucose uptake (via GLUT-4 in muscle and adipose)
Activates glycogen synthase (glycogenesis)
Activates PFK-1 (glycolysis)
Inhibits glycogen phosphorylase (anti-glycogenolysis)
Inhibits gluconeogenesis
Promotes fatty acid synthesis (activates acetyl-CoA carboxylase)
Inhibits lipolysis (inhibits HSL - hormone sensitive lipase)
Promotes protein synthesis

Q: What is glucagon? Opposite of insulin? A: Peptide hormone from alpha cells of islets. Secreted in response to low blood glucose. Catabolic:

Activates glycogenolysis (via cAMP → PKA → glycogen phosphorylase)
Activates gluconeogenesis
Activates lipolysis → fatty acids → ketogenesis
Inhibits glycogen synthase

⏱ UNIT 10: WATER, ELECTROLYTE & ACID-BASE BALANCE (~10 min)

Q: What are the body fluid compartments? A: Total body water (TBW) = 60% of body weight (40L in 70 kg man).

Intracellular fluid (ICF): 40% BW = 28L; major cation K⁺
Extracellular fluid (ECF): 20% BW = 14L; major cation Na⁺
- Plasma: 3L
- Interstitial fluid: 11L
- Transcellular: small amount

Q: What is osmolarity vs. osmolality? What is normal plasma osmolality? A: Osmolality = solute particles per kg water (mOsm/kg). Normal plasma osmolality: 280-295 mOsm/kg. Formula: 2[Na⁺] + [Glucose]/18 + [BUN]/2.8. Regulated mainly by ADH (antidiuretic hormone).

Q: What are the 4 acid-base disturbances? A: Normal pH = 7.35-7.45. Normal HCO₃⁻ = 22-26 mEq/L. Normal pCO₂ = 35-45 mmHg.

Disturbance	pH	Primary change	Compensation
Metabolic acidosis	↓	HCO₃⁻ ↓	Hyperventilation (↓ pCO₂) - Kussmaul breathing
Metabolic alkalosis	↑	HCO₃⁻ ↑	Hypoventilation (↑ pCO₂)
Respiratory acidosis	↓	pCO₂ ↑	Kidney retains HCO₃⁻
Respiratory alkalosis	↑	pCO₂ ↓	Kidney excretes HCO₃⁻

Q: What is the anion gap? A: AG = [Na⁺] - ([Cl⁻] + [HCO₃⁻]) = 8-12 mEq/L normally. Elevated AG metabolic acidosis: MUDPILES - Methanol, Uremia, Diabetic ketoacidosis, Propylene glycol, Isoniazid/Iron, Lactic acidosis, Ethanol, Salicylates.

⏱ UNIT 11: PLASMA PROTEINS (~10 min)

Q: Name the plasma proteins and their functions. A:

Protein	Normal level	Function
Total protein	6-8 g/dL	Colloid osmotic pressure, transport
Albumin	3.5-5 g/dL	Oncotic pressure (75%), transport (bilirubin, fatty acids, drugs, Ca²⁺), buffer
Globulins	2-3.5 g/dL	Immunoglobulins (immunity), transport
Fibrinogen	200-400 mg/dL	Coagulation
A:G ratio	1.5-2.5:1	Decreased in liver disease, nephrotic syndrome

Q: What are acute phase proteins? A: Proteins that increase rapidly in response to infection/inflammation (produced by liver under IL-6 stimulus):

C-reactive protein (CRP) - most sensitive marker; binds phosphocholine on microbes; activates complement
Serum amyloid A (SAA)
Fibrinogen, alpha-1 antitrypsin, haptoglobin, ferritin, ceruloplasmin, complement
Albumin and transferrin DECREASE (negative acute phase reactants)

Q: What is CRP and its significance? A: Acute phase protein made by liver. Normal <6 mg/L; elevated in infection, inflammation, MI. High-sensitivity CRP (hs-CRP): cardiovascular risk marker. Faster to rise than ESR; falls faster.

Q: What is serum protein electrophoresis? A: Proteins separated by charge in electric field → 5 bands: Albumin (largest), alpha-1, alpha-2, beta, gamma globulins. Paraprotein (M-band) in gamma region → multiple myeloma, Waldenström's. Decreased gamma → immunodeficiency.

⏱ UNIT 12: CLINICAL BIOCHEMISTRY / LFT / RFT (~10 min)

Q: What are liver function tests (LFTs)? A:

Test	Normal	Significance
Serum bilirubin (total)	<1.0 mg/dL	Jaundice >2.5 mg/dL
SGPT (ALT)	7-56 IU/L	Hepatocellular damage (specific)
SGOT (AST)	10-40 IU/L	Hepatocellular + cardiac + muscle
ALP	30-120 IU/L	Cholestasis, bone disease
GGT	5-50 IU/L	Alcoholic liver disease, cholestasis
Serum albumin	3.5-5 g/dL	Synthetic function of liver
PT/INR	11-13s / 1.0	Coagulation (liver synthesis factors II,V,VII,X)

Q: What are renal function tests (RFTs)? A:

Test	Normal	Significance
Blood urea	7-20 mg/dL	Protein catabolism + GFR
Serum creatinine	0.6-1.2 mg/dL	GFR (more reliable than urea)
Uric acid	3.5-7.0 mg/dL (male)	Gout, renal disease
GFR	>90 mL/min/1.73m²	Cockcroft-Gault or CKD-EPI formula
Urine routine	-	Proteinuria, glucosuria, casts

Q: What is creatinine clearance? Why is it preferred? A: Volume of plasma cleared of creatinine per minute. Approximates GFR. Preferred because creatinine is freely filtered and minimally secreted (urea is reabsorbed → overestimates GFR; creatinine is more accurate). Cockcroft-Gault: CrCl = [(140-age) × weight] / (72 × Cr) × 0.85 (female).

⏱ UNIT 13: INBORN ERRORS OF METABOLISM (Quick recap)

Disease	Enzyme Defect	Substrate Accumulated	Feature
PKU	Phenylalanine hydroxylase	Phenylalanine	Intellectual disability, mousy urine, fair skin
Alkaptonuria	Homogentisate oxidase	Homogentisic acid	Dark urine, ochronosis
Maple syrup urine	BCKA dehydrogenase	Leu, Ile, Val	Maple syrup urine
Homocystinuria	Cystathionine beta-synthase	Homocysteine	Marfanoid features, DVT, lens dislocation
Albinism	Tyrosinase	Melanin absent	Lack of pigment, photosensitivity
G6PD deficiency	G6PD	NADPH deficiency	Hemolytic anemia with oxidants
Galactosemia	Gal-1-P uridyltransferase	Galactose-1-P	Cataracts, liver damage, E. coli sepsis
Glycogen storage (Von Gierke, Type I)	G6Pase	Glycogen in liver	Fasting hypoglycemia, hepatomegaly, hyperlipidemia, hyperuricemia
Gaucher's	Glucocerebrosidase	Glucocerebroside	Hepatosplenomegaly, bone pain
Niemann-Pick	Sphingomyelinase	Sphingomyelin	Hepatosplenomegaly, cherry-red spot
Tay-Sachs	Hexosaminidase A	GM2 ganglioside	Cherry-red spot, neurodegeneration (no hepatosplenomegaly)
Lesch-Nyhan	HGPRT	Uric acid	Gout, self-mutilation
Fabry's	Alpha-galactosidase A	Globotriaosylceramide	Renal failure, angiokeratoma

⚡ LAST-MINUTE HIGH-YIELD MEMORY AIDS

Reducing sugars: All monosaccharides + Maltose + Lactose. NOT sucrose.

Rate-limiting enzymes:

Glycolysis: PFK-1
Gluconeogenesis: Pyruvate carboxylase / PEPCK
Glycogenesis: Glycogen synthase
Glycogenolysis: Glycogen phosphorylase
HMP shunt: G6PD
Fatty acid synthesis: Acetyl-CoA carboxylase
Fatty acid oxidation: Carnitine acyltransferase I (entry step)
Cholesterol synthesis: HMG-CoA reductase
Urea cycle: CPS-I
Heme synthesis: ALA synthase
Ketogenesis: HMG-CoA synthase

TCA cycle products per turn: 3 NADH, 1 FADH₂, 1 GTP, 2 CO₂

ATP yields: NADH = 2.5 ATP; FADH₂ = 1.5 ATP; GTP = 1 ATP

Vitamins and their unique diseases:

B1 → Beriberi, Wernicke-Korsakoff
B3 → Pellagra (3 Ds)
B6 → Convulsions in infants, sideroblastic anemia
B9 → Neural tube defects (supplement in pregnancy)
B12 → Pernicious anemia + subacute combined degeneration
C → Scurvy (bleeding gums, corkscrew hair)
D → Rickets / Osteomalacia
K → Bleeding (↑PT) - warfarin antagonist

"GLUT" transporters:

GLUT-1: RBCs, brain (constant)
GLUT-2: Liver, pancreatic B cells, kidney, intestine (high Km, sensor)
GLUT-3: Neurons
GLUT-4: Muscle, adipose (insulin-dependent)

Enzyme inhibitors (drugs):

Statins → HMG-CoA reductase (↓ cholesterol)
Methotrexate → DHFR (↓ folate → ↓ DNA synthesis)
Allopurinol → Xanthine oxidase (↓ uric acid)
NSAIDs → COX (↓ prostaglandins)
Aspirin → irreversible COX inhibition (antiplatelet)
Penicillin → transpeptidase (cell wall synthesis)

You've now covered the entire MBBS 1st Year Biochemistry syllabus in viva Q&A format. Go through each unit, cover the answer, say it out loud, then check. Good luck with your viva! 🎯

Viva from vitamin and mineral and vitamin which can be covered in 10 min w

Here is your 10-minute Vitamins & Minerals Viva - only the highest-yield questions an examiner will ask. Read Q, say answer aloud, check.

⚡ VITAMINS & MINERALS VIVA - 10 MIN SPRINT

🅰️ FAT-SOLUBLE VITAMINS (A, D, E, K)

Q: Which vitamins are fat-soluble? A: A, D, E, K - stored in liver/fat, can cause toxicity with excess.

Q: What is the active form of Vitamin A? A: Retinol (storage/transport), Retinal (vision), Retinoic acid (gene expression, growth). Provitamin A = beta-carotene (from carrots, green leafy veg).

Q: What is the role of Vitamin A in vision? A: Retinal + Opsin → Rhodopsin (in rod cells). Light → 11-cis-retinal converts to all-trans-retinal → nerve impulse → vision. Regeneration requires Vit A. Deficiency → rods fail → Night blindness (first sign).

Q: What are the signs of Vitamin A deficiency? A:

Night blindness (nyctalopia) - first and earliest sign
Xerophthalmia (dry eye)
Bitot's spots (foamy white patches on conjunctiva)
Keratomalacia (corneal softening/ulceration) → blindness
Follicular hyperkeratosis (toad skin)
Impaired immunity, growth retardation

Q: Vitamin A toxicity signs? A: Headache (raised ICP/pseudotumor cerebri), alopecia, hepatomegaly, dry skin, teratogenic (avoid high-dose in pregnancy).

Q: What is the active form of Vitamin D? A: 1,25-dihydroxycholecalciferol = Calcitriol (most active). Synthesis pathway: 7-dehydrocholesterol (skin + UV) → Cholecalciferol (D3) → Liver 25-hydroxylation → 25-OH-D3 (storage form, measured in blood) → Kidney 1-alpha-hydroxylation (rate-limiting, stimulated by PTH) → Calcitriol.

Q: What does Vitamin D do? A: Increases intestinal absorption of Ca²⁺ and phosphate. Promotes bone mineralization. Suppresses PTH.

Q: Vitamin D deficiency diseases? A: Children → Rickets (soft bones, bowing of legs, rachitic rosary, Harrison's sulcus, craniotabes). Adults → Osteomalacia (bone pain, proximal muscle weakness, Looser zones on X-ray).

Q: What stimulates renal 1-alpha-hydroxylase? A: PTH, hypocalcemia, hypophosphatemia.

Q: What is Vitamin E's main function? A: Antioxidant - protects polyunsaturated fatty acids (PUFAs) in cell membranes from lipid peroxidation by scavenging free radicals. Works with selenium (glutathione peroxidase).

Q: Vitamin E deficiency? A: Hemolytic anemia (premature infants, especially), spinocerebellar ataxia, peripheral neuropathy, areflexia. Rare in adults.

Q: What is the role of Vitamin K? A: Cofactor for gamma-carboxylation of glutamate residues in clotting factors II (prothrombin), VII, IX, X (and anticoagulant proteins C and S). Carboxylation makes them Ca²⁺-binding and functional.

Q: What is the mechanism of warfarin? A: Warfarin inhibits Vitamin K epoxide reductase → blocks recycling of Vitamin K → clotting factors II, VII, IX, X not gamma-carboxylated → anticoagulation. Antidote: Vitamin K (slow) or FFP (fast).

Q: Vitamin K deficiency causes? A: Bleeding - prolonged PT (prothrombin time) is first sign (factor VII has shortest half-life). Causes: neonates (low gut bacteria, no placental transfer → give Vit K injection at birth), prolonged antibiotics, fat malabsorption.

🅱️ WATER-SOLUBLE VITAMINS

Q: Vitamin B1 (Thiamine) - coenzyme form? A: TPP (Thiamine Pyrophosphate). Required for:

Pyruvate dehydrogenase (pyruvate → acetyl-CoA)
Alpha-ketoglutarate dehydrogenase (TCA cycle)
Transketolase (HMP shunt) ← most sensitive marker of deficiency

Q: Deficiency diseases of B1? A:

Dry Beriberi: peripheral polyneuropathy (glove & stocking pattern), weakness
Wet Beriberi: high-output cardiac failure, edema, cardiomegaly
Wernicke's encephalopathy (in alcoholics): nystagmus, ataxia, confusion (classic triad)
Korsakoff psychosis: anterograde amnesia, confabulation (chronic, irreversible)

Q: Vitamin B2 (Riboflavin) - coenzyme form? A: FAD and FMN. Used in ETC (Complex I, II), beta-oxidation, TCA.

Q: B2 deficiency signs? A: Ariboflavinosis: Angular stomatitis (cracking at corners of mouth), cheilosis, glossitis (magenta tongue), corneal vascularization, scrotal/vulval dermatitis, photophobia.

Q: Vitamin B3 (Niacin) - coenzyme form? A: NAD⁺ and NADP⁺. NAD⁺ - catabolic (glycolysis, TCA, beta-oxidation). NADP⁺ - anabolic (HMP shunt, fatty acid synthesis).

Q: B3 deficiency disease? A: Pellagra - "4 Ds": Dermatitis (photosensitive, Casal's necklace), Diarrhoea, Dementia, Death (if untreated).

Q: How is niacin obtained from tryptophan? A: 60 mg tryptophan → 1 mg niacin (requires B6, B2, B3 cofactors). That's why corn-based diets (low Trp) + B6 deficiency cause pellagra. Hartnup disease: defective intestinal tryptophan transport → pellagra-like.

Q: What is the pharmacological use of niacin? A: High-dose niacin raises HDL cholesterol (most effective agent for raising HDL), lowers TG and LDL. Side effect: flushing (prostaglandin-mediated, blocked by aspirin).

Q: Vitamin B5 (Pantothenic acid) - role? A: Component of Coenzyme A (CoA). Essential for acetyl-CoA formation, TCA cycle, fatty acid synthesis and oxidation. Deficiency very rare (burning feet syndrome).

Q: Vitamin B6 (Pyridoxine) - coenzyme form? A: PLP (Pyridoxal Phosphate). Required for:

Transamination (SGOT, SGPT)
Decarboxylation (synthesis of serotonin, dopamine, GABA, histamine)
ALA synthase (heme synthesis - first step)
Glycogen phosphorylase

Q: B6 deficiency? A: Peripheral neuropathy, convulsions in infants (low GABA synthesis), sideroblastic anemia (heme synthesis impaired), cheilosis, glossitis. Caused by: isoniazid (INH) therapy (B6 antagonist → give B6 with INH prophylactically).

Q: Vitamin B7 (Biotin) - role? A: Cofactor for carboxylation reactions (CO₂ transfer):

Pyruvate carboxylase (gluconeogenesis)
Acetyl-CoA carboxylase (fatty acid synthesis)
Propionyl-CoA carboxylase (odd-chain FA metabolism)

Q: What causes biotin deficiency? A: Raw egg white consumption (avidin in egg white binds biotin irreversibly). Prolonged antibiotic use. Features: alopecia, dermatitis, ataxia.

Q: Vitamin B9 (Folic acid) - coenzyme form? A: THF (Tetrahydrofolate) - carries one-carbon units (formyl, methyl groups). Essential for:

Purine synthesis (de novo)
Thymidylate synthesis (dTMP from dUMP - via thymidylate synthase)
Methionine synthesis (from homocysteine, with B12)

Q: Folate deficiency effects? A: Megaloblastic anemia (large RBCs, hypersegmented neutrophils - 5+ lobes). Neural tube defects in fetus (spina bifida, anencephaly) - hence folic acid supplementation before and during early pregnancy. NO neurological features (unlike B12).

Q: What is the methyl-folate trap? A: B12 is needed to convert 5-methyl-THF → THF (recycling). Without B12, folate is "trapped" as 5-methyl-THF → cannot be used → functional folate deficiency → same megaloblastic anemia picture even if folate is adequate.

Q: Vitamin B12 (Cobalamin) - absorption? A: B12 + Intrinsic Factor (IF) (secreted by gastric parietal cells) → complex absorbed in terminal ileum. Without IF → Pernicious anemia (autoimmune anti-parietal cell/anti-IF antibodies).

Q: What are the two B12-dependent reactions? A:

Methionine synthase: Homocysteine + 5-methyl-THF → Methionine + THF (requires methylcobalamin)
Methylmalonyl-CoA mutase: Methylmalonyl-CoA → Succinyl-CoA (requires adenosylcobalamin; odd-chain FA and branched AA catabolism)

Q: B12 deficiency features? A:

Megaloblastic anemia (macro-ovalocytes, hypersegmented neutrophils)
Subacute combined degeneration of spinal cord (SACDSC): posterior columns (vibration/proprioception loss, ataxia) + lateral columns (UMN signs) - due to myelin damage
Glossitis, angular stomatitis
Increased methylmalonic acid + homocysteine in blood (diagnostic markers)

Q: How to distinguish B12 vs. folate deficiency megaloblastic anemia? A:

	B12 deficiency	Folate deficiency
Neurological signs	Present (SACDSC)	Absent
Serum methylmalonic acid	Elevated	Normal
Serum homocysteine	Elevated	Elevated
Response to folate	NO (neuro worsens)	Yes

Q: Vitamin C (Ascorbic acid) - main biochemical role? A: Cofactor for prolyl hydroxylase and lysyl hydroxylase → hydroxylation of proline and lysine in collagen synthesis → cross-linking → structural integrity of collagen. Also: antioxidant (regenerates Vit E), enhances non-heme iron absorption (reduces Fe³⁺ → Fe²⁺), dopamine-beta-hydroxylase (norepinephrine synthesis).

Q: Scurvy (Vit C deficiency) features? A: All due to defective collagen:

Perifollicular hemorrhage (corkscrew/coiled hairs)
Bleeding gums, gingivitis, loose teeth
Poor wound healing
Subperiosteal hemorrhage (bone pain in children)
Woody leg (children), Scorbutic rosary
Hyperkeratosis
Anemia (Fe malabsorption)

🪨 MINERALS - HIGH YIELD

Q: Functions of iron in the body? A: Component of hemoglobin (O₂ transport), myoglobin, cytochromes (ETC), catalase, peroxidase, ribonucleotide reductase (DNA synthesis).

Q: Iron absorption - where and how? A: Duodenum and upper jejunum. Heme iron (from meat) absorbed directly and better. Non-heme iron (Fe³⁺) must be reduced to Fe²⁺ by ferric reductase (Dcytb) or Vit C → absorbed by DMT-1 transporter. Stored in enterocyte as ferritin or exported by ferroportin.

Q: How is iron transported in blood? A: Bound to transferrin (Fe³⁺, 2 binding sites). TIBC = total iron binding capacity (reflects transferrin). Normal serum iron: 60-180 µg/dL. Transferrin saturation = serum iron/TIBC × 100 (normal ~30%).

Q: Iron stores - forms? A: Ferritin (soluble, physiological store; serum ferritin reflects body iron stores - low in deficiency). Hemosiderin (insoluble aggregate of ferritin; accumulates in overload = hemosiderosis).

Q: What is hepcidin? A: Peptide hormone from liver - master regulator of iron homeostasis. Binds ferroportin → internalization and degradation → iron trapped in enterocytes and macrophages → less iron absorbed/released. Increased in: infection, inflammation, iron overload. Decreased in: iron deficiency, hypoxia, anemia. Anemia of chronic disease = high hepcidin → iron trapped.

Q: Iron deficiency anemia lab findings? A: Low Hb, microcytic hypochromic RBCs, low serum iron, low ferritin (most sensitive marker), high TIBC, low transferrin saturation, high RDW (anisocytosis). Blood film: pencil cells, target cells.

Q: Iron overload - causes and effects? A: Hemochromatosis (AR, HFE gene mutation, most common genetic iron overload): iron deposits in liver (cirrhosis), pancreas (diabetes - "bronze diabetes"), heart (cardiomyopathy), joints, skin (bronze pigmentation). "Bronze diabetes" = classic triad. Treatment: phlebotomy, deferoxamine.

Q: Calcium in body - distribution and function? A: 99% in bones (hydroxyapatite). 1% extracellular. Serum Ca: 8.5-10.5 mg/dL (50% ionized/free Ca²⁺ = active; 40% albumin-bound; 10% complexed). Functions: muscle contraction, nerve conduction, coagulation (cofactor), enzyme activation, bone structure.

Q: Calcium regulation - 3 hormones? A:

PTH (parathyroid): ↑Ca²⁺ (bone resorption + renal reabsorption + activates Vit D); ↓phosphate
Calcitriol (Vit D): ↑Ca²⁺ and phosphate absorption from gut
Calcitonin (thyroid C-cells): ↓Ca²⁺ (opposes PTH; minor role in adults)

Q: Hypocalcemia signs? A: Tetany - muscle spasms, carpopedal spasm. Chvostek's sign (tap facial nerve → facial muscle twitch). Trousseau's sign (inflate BP cuff → carpopedal spasm). Prolonged QT on ECG, convulsions.

Q: What is the role of zinc? A: Cofactor for >300 enzymes (carbonic anhydrase, carboxypeptidase, alkaline phosphatase, DNA/RNA polymerase). Wound healing, immune function, taste/smell (gustin), spermatogenesis. Deficiency: acrodermatitis enteropathica (AR, defective Zn absorption), dermatitis, diarrhea, alopecia, hypogonadism, poor wound healing, anosmia/ageusia.

Q: What is the role of iodine? A: Component of thyroid hormones T3 (triiodothyronine) and T4 (thyroxine). Deficiency → goiter (enlarged thyroid), hypothyroidism, cretinism (congenital - intellectual disability, short stature, deafness, goiter).

Q: What is selenium's role? A: Component of glutathione peroxidase (GPx) → reduces H₂O₂ and lipid peroxides → antioxidant defense. Works with Vit E. Deficiency: Keshan disease (cardiomyopathy, in China), myopathy.

Q: What is fluoride's role? A: Incorporated into fluoroapatite in bones and teeth → harder, more acid-resistant enamel → prevents dental caries. Excess → dental fluorosis (mottled enamel) → skeletal fluorosis (joint stiffness, osteosclerosis).

Q: Copper - transport and disorders? A: Absorbed in duodenum → albumin → liver → ceruloplasmin (main carrier, ferroxidase activity, oxidizes Fe²⁺ → Fe³⁺ for loading onto transferrin).

Wilson's disease (AR, ATP7B mutation): Cu accumulates in liver, brain, kidney → cirrhosis, neuropsychiatric, Kayser-Fleischer rings (greenish-brown rings in cornea), low ceruloplasmin. Treatment: D-penicillamine.
Menkes disease (X-linked, ATP7A): defective Cu absorption → low copper, kinky/steely hair, neurodegeneration, connective tissue defects.

⚡ MUST-KNOW ONE-LINERS

Vitamin/Mineral	Key One-liner
A	Night blindness = first sign of deficiency
D	Rickets in children, Osteomalacia in adults
E	Antioxidant, protects PUFAs from lipid peroxidation
K	Gamma-carboxylation of clotting factors; warfarin blocks its recycling
B1	TPP; Beriberi + Wernicke-Korsakoff (alcoholics)
B2	FAD/FMN; Angular stomatitis, cheilosis
B3	NAD⁺/NADP⁺; Pellagra (4 Ds)
B6	PLP; Convulsions in infants; INH causes deficiency
B7	Biotin; Raw egg white causes deficiency (avidin)
B9	THF; Megaloblastic anemia; Neural tube defects in pregnancy
B12	IF needed; Megaloblastic anemia + subacute combined degeneration
C	Collagen hydroxylation; Scurvy = bleeding gums + corkscrew hair
Iron	Ferritin = best marker of stores; Hepcidin = master regulator
Calcium	PTH, Vit D, Calcitonin; Tetany = hypocalcemia
Copper	Ceruloplasmin; Wilson's = KF rings, low ceruloplasmin
Zinc	>300 enzymes; deficiency = dermatitis + anosmia
Iodine	T3/T4; deficiency = goiter + cretinism
Selenium	Glutathione peroxidase; Keshan disease

That's the entire Vitamins & Minerals topic in 10 minutes flat. Good luck! 🎯

This is a shared conversation. Sign in to Orris to start your own chat.